2, 2023 /PRNewswire/ -- BodySpec, the leader in advanced mobile body composition scans, warns that a significant proportion of the weight loss seen with GLP-1 drugs, such as Ozempic, Wegovy, and Mounjaro, may be lean tissue
All products sold by Polar Peptides are intended strictly for research use only and are not intended for human consumption, medical use, diagnostic use, or any other unauthorized use
The search strategy combines Medical Subject Headings (MeSH) and keywords including GLP-1, glucagon-like peptide-1 receptor, GLP-1 receptor agonist, sepsis, systemic inflammation, infection, immune response, critical illness, MODS, multiple organ dysfunction, cytokines and sepsis treatment. Articles were screened for relevance based on titles and abstracts, with full-text evaluation of studies addressing the mechanistic or therapeutic implications of GLP-1 signaling in experimental or clinical models of sepsis
[4] [5] Such development typically takes many years and must meet rigorous regulatory standards set by the MHRA and European Medicines Agency (EMA) before any product could be approved for patient use
